SenesTech
Flagstaff
About SenesTech
SenesTech is a biotech platform and research company that has developed an innovative technology for managing animal populations by fertility control. They develop non-lethal treatments that have the potential to be more effective, more humane, and less invasive to the environment than traditional management methods. SenesTech’s first product applies their revolutionary technology to a worldwide problem that has persisted since the Middle Ages: the proliferation of rats in both urban and agricultural settings. Their innovative compound is readily consumed by rats and leaves them non-reproductive with no other observable side effects. The rodents live out their normal 8-12 month life span without producing offspring. Since rapid reproduction is the root cause of rat infestation, this introduces a new paradigm to the science of pest control. When used as directed, their species-specific formulation is environmentally neutral, does not affect non-target animals, and has no impact on human health or fertility.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $34.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: nasdaq:SNES
- Website: senestech.com
- Phone: (928)779-4143
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/senestech-17055 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.